Latest Breaking News On - Antengene corporation - Page 6 : comparemela.com

Antengene to Release Latest Results from the TORCH-2 Trial of mTORC1/2 Inhibitor ATG-008 in Poster Discussion at 2023 ASCO

Antengene to Release Latest Results from the TORCH-2 Trial of mTORC1/2 Inhibitor ATG-008 in Poster Discussion at 2023 ASCO
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Mccormick placeUnited statesSouth koreaHong kongAsia pacificPeter qianAntengene corporationCompany annualPrnewswire antengene corporation limitedHong kong stock exchangeMccormick place convention centerAntengene corporation limitedAmerican society for clinical oncology annual meetingCorporation limitedAmerican societyClinical oncology annual meeting

Global CD276 Antibody Clinical Trials & Markets Report 2023: Potential $1 Billion Market by 2028, 30 Drugs in Trial, Orphan & Priority Status Review, Insight on 25 Companies

/PRNewswire/ The "Global CD276 Antibody Clinical Trials & Market Sales Forecast 2028" report has been added to ResearchAndMarkets.com s offering. This.

United statesBoyuan runsheng pharmaAleta biotherapeuticsDaiichi sankyoPersongen biotherapeuticsMultispecific bispecific trispecificLaura woodSarah cannon research instituteDesignations in promoting developmentAntengene corporationE st office hours callKati medical technologyAntibody clinical trials by companyMemorial sloan kettering cancer centerDaiichi sankyo companyOffice hours call

Antengene Announces Results for Full Year 2022 with Updates Highlighting a Sales Revenue Reaching 5 6 Times Year-Over-Year and Accelerated Global Innovation

/PRNewswire/ Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), today announced its full-year 2022 financial results and provided updates on key.

Hong kongSouth koreaJay meiAsia pacificPeter qianAntengene corporation limitedBank balance to provide runwayCompany annualPrnewswire antengene corporation limitedAntengene corporationHong kong stock exchangeCorporation limitedRevenue reachedAdjusted loss narrowedBest in class potential clinical programsValue drivers

Antengene Announces Five Upcoming Presentations at the 2023 American Association for Cancer Research Annual Meeting

/PRNewswire/ Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, global biopharmaceutical company dedicated to discovering,.

Bo shanUnited statesHong kongOrange county convention centerSouth koreaAsia pacificPeter qianCompany annualAntengene corporationAmerican association for cancer research annual meetingHong kong stock exchangePrnewswire antengene corporation limitedAntengene corporation limitedCorporation limitedCancer research annual meetingChief scientific

Oricell Publishes Data from POLARIS Clinical Study Evaluating OriCAR-017 in the Treatment of RRMM in The Lancet Haematology

Oricell Publishes Data from POLARIS Clinical Study Evaluating OriCAR-017 in the Treatment of RRMM in The Lancet Haematology
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesHelen yangSchool of medicineAntengene corporationAmerican society of clinical oncologyDrug administrationBone marrow transplantation centerCentre single arm studyPrnewswire oricell therapeutics co ltdZhejiang universityLabel single centre arm studyRefractory multiple myelomaLancet haematologyFirst affiliated hospitalAmerican societyClinical oncology